Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wim Ceelen, Marc De Man, Wouter Willaert, Gabrielle H. van Ramshorst, Karen Geboes & Anne Hoorens. (2021) Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei: diagnostic and therapeutic algorithms based on current evidence. Acta Chirurgica Belgica 121:4, pages 225-234.
Read now
Read now
Articles from other publishers (19)
Suiting Ye & Song Zheng. (2022) Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei. American Journal of Clinical Oncology 45:5, pages 223-231.
Crossref
Crossref
Madeleine C. Strach, Sarah Sutherland, Lisa G. Horvath & Kate Mahon. (2022) The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions. Therapeutic Advances in Medical Oncology 14, pages 175883592211124.
Crossref
Crossref
Matthias Barral, Imane El-Sanharawi, Anthony Dohan, Maxime Sebuhyan, Alexis Guedon, Audrey Delarue, Alexandre Boutigny, Nassim Mohamedi, Benjamin Magnan, Salim Kemel, Chahinez Ketfi, Nathalie Kubis, Annouk Bisdorff-Bresson, Marc Pocard & Philippe Bonnin. (2021) Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor Diseases. Frontiers in Physiology 12.
Crossref
Crossref
Yvonne Andersson, Karianne G. Fleten, Torveig W. Abrahamsen, Wenche Reed, Ben Davidson & Kjersti Flatmark. (2021) Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale. Cancers 13:11, pages 2819.
Crossref
Crossref
Sakura Hiraide, Keigo Komine, Yuko Sato, Kota Ouchi, Hiroo Imai, Ken Saijo, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi & Chikashi Ishioka. (2019) Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei. International Journal of Clinical Oncology 25:4, pages 774-781.
Crossref
Crossref
Matthias Barral, Imane El Sanharawi, Clarisse Eveno, Anthony Dohan, Jean-Marie Launay, Réa Lo Dico, Marc Pocard & Philippe Bonnin. (2019) Post-operative wall shear stress in the superior mesenteric artery: Biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei. European Journal of Surgical Oncology 45:9, pages 1727-1733.
Crossref
Crossref
Alessandra Raimondi, Salvatore Corallo, Monica Niger, Maria Antista, Giovanni Randon, Federica Morano, Massimo Milione, Shigeki Kusamura, Dario Baratti, Marcello Guaglio, Chiara Cremolini, Federica Marmorino, Maria Di Bartolomeo, Marcello Deraco, Filippo De Braud & Filippo Pietrantonio. (2019) Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei. Clinical Colorectal Cancer 18:2, pages e179-e190.
Crossref
Crossref
J.-B. Delhorme, C. Honoré, L. Benhaim, F. Dumont, P. Dartigues, C. Dromain, M. Ducreux, D. Elias & D. Goéré. (2017) Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. European Journal of Surgical Oncology (EJSO) 43:1, pages 159-167.
Crossref
Crossref
Filippo Pietrantonio, Rosa Berenato, Claudia Maggi, Marta Caporale, Massimo Milione, Federica Perrone, Elena Tamborini, Dario Baratti, Shigeki Kusamura, Luigi Mariani, Monica Niger, Alessia Mennitto, Annunziata Gloghini, Ilaria Bossi, Giulio Settanni, Adele Busico, Pietro Francesco Bagnoli, Maria Di Bartolomeo, Marcello Deraco & Filippo de Braud. (2016) GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Journal of Translational Medicine 14:1.
Crossref
Crossref
Laura A. Lambert. (2015) Looking up: Recent advances in understanding and treating peritoneal carcinomatosis. CA: A Cancer Journal for Clinicians 65:4, pages 283-298.
Crossref
Crossref
Marco Vaira, Manuela Robella, Alfredo Mellano & Michele De Simone. 2015. Treatment of Peritoneal Surface Malignancies. Treatment of Peritoneal Surface Malignancies
227
242
.
. (2014) IV. Les recommandations. Journal de Chirurgie Viscérale 151:6, pages S15-S63.
Crossref
Crossref
Filippo Pietrantonio, Claudia Maggi, Giuseppe Fanetti, Roberto Iacovelli, Maria Di Bartolomeo, Francesca Ricchini, Marcello Deraco, Federica Perrone, Dario Baratti, Shigeki Kusamura, Elena Tamborini, Alessandra Castano, Paola Valentina Consonni, Ilaria Bossi, Cecilia Gavazzi, Massimo Milione, Giuseppe Pelosi & Filippo de Braud. (2014) FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma. The Oncologist 19:8, pages 845-850.
Crossref
Crossref
Anthony Dohan, Ruben Lousquy, Clarisse Eveno, Diane Goere, Dong Broqueres-You, Rachid Kaci, Jacqueline Lehmann-Che, Jean-Marie Launay, Philippe Soyer, Philippe Bonnin & Marc Pocard. (2014) Orthotopic Animal Model of Pseudomyxoma Peritonei. The American Journal of Pathology 184:7, pages 1920-1929.
Crossref
Crossref
G. Passot, N. Bakrin, L. Garnier, A. Roux, D. Vaudoyer, F. Wallet, F.N. Gilly, O. Glehen & E. Cotte. (2014) Intraperitoneal vascular endothelial growth factor burden in peritoneal surface malignancies treated with curative intent: The first step before intraperitoneal anti-vascular endothelial growth factor treatment?. European Journal of Cancer 50:4, pages 722-730.
Crossref
Crossref
W.A. Jimenez, A. Sardi, P. Ledakis, C. Nieroda, M. Sittig & V. Gushchin. (2013) The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer. European Journal of Surgical Oncology (EJSO) 39:12, pages 1415-1422.
Crossref
Crossref
Guillaume Passot, Aurélien Dupré, Michel Rivoire, Faheez Mohamed, Naoual Bakrin & Olivier Glehen. (2012) Intraperitoneal bevacizumab combined with cytoreductive surgery: a pre-clinical study of tolerance and pharmacokinetics in an animal model. Clinical and Translational Oncology 14:12, pages 931-936.
Crossref
Crossref
Akiyoshi MIZUMOTO, Masamitsu HIRANO, Nobuyuki TAKAO, Takayuki MATSUDA, Masumi ICHINOSE & Yutaka YONEMURA. (2012) Successful treatment of two cases of pseudomyxoma peritonei preserving pregnancy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 73:1, pages 187-193.
Crossref
Crossref
Kjersti Flatmark, Ben Davidson, Alexandr Kristian, Helene Tuft Stavnes, Mette Førsund & Wenche Reed. (2010) Exploring the peritoneal surface malignancy phenotype—a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Human Pathology 41:8, pages 1109-1119.
Crossref
Crossref